Description
9th Biosimilars Conference 2011 deals with emerging markets with a focus on the far east; biosimilars regulation and legal aspects; biosimilars commercial and economic prospects;designing the manufacturing process ; preclinical testing; clinical development of biosimilars; monoclonal antibodies.
The event brings together Executives, managers and researchers from Biologics, Biopharmaceuticals, Biogenerics, Biotechnology, Pharmacovigilance, R&D, Clinical Immunology, Drug and patient Safety and more.
